{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:32:59Z","timestamp":1793223179195,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002535"],"award-info":[{"award-number":["UL1 TR002535"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UM1 TR004399"],"award-info":[{"award-number":["UM1 TR004399"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011866","name":"University of Colorado Anschutz Colorado Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jbc.2026.113508","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:49:27Z","timestamp":1787924967000},"page":"113508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Farnesoid X receptor activates STAT3 to promote fatty acid oxidation and suppress inflammatory macrophage responses in cholestasis"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1902-8025","authenticated-orcid":false,"given":"Swati","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Devereaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7815-2416","authenticated-orcid":false,"given":"Colin C.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1674-0997","authenticated-orcid":false,"given":"Amy","family":"Argabright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0417-1400","authenticated-orcid":false,"given":"David J.","family":"Orlicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7433-4095","authenticated-orcid":false,"given":"Ronald J.","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.113508_bib1","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1152\/physrev.00022.2025","article-title":"Cholangiocyte biology in primary sclerosing cholangitis and other cholangiopathies: pathogenesis, clinical insights, and experimental tools","volume":"106","author":"Jalan-Sakrikar","year":"2026","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jbc.2026.113508_bib2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.aaz6964","article-title":"Cholangiocyte organoids can repair bile ducts after transplantation in the human liver","volume":"371","author":"Sampaziotis","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.113508_bib3","article-title":"Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progression","volume":"7","author":"Laschtowitz","year":"2025","journal-title":"JHEP Rep."},{"key":"10.1016\/j.jbc.2026.113508_bib4","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jbc.2026.113508_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/BST20210658","article-title":"Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders","volume":"50","author":"Molinaro","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jbc.2026.113508_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/164_2019_231","article-title":"Targeting FXR in cholestasis","volume":"256","author":"Keitel","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.jbc.2026.113508_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.32101","article-title":"Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice","volume":"75","author":"El Kasmi","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2026.113508_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000056","article-title":"Stat3 role in the protective effect of FXR agonist in parenteral nutrition-associated cholestasis","volume":"7","author":"Ghosh","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jbc.2026.113508_bib9","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2174\/1381612824666180327165604","article-title":"Signaling pathways in inflammation and anti-inflammatory therapies","volume":"24","author":"Yeung","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jbc.2026.113508_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000505099","article-title":"Interleukin-6: A Masterplayer in the cytokine network","volume":"98","author":"Uciechowski","year":"2020","journal-title":"Oncology"},{"key":"10.1016\/j.jbc.2026.113508_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121663","article-title":"gamma-Mangostin abrogates AINT-induced cholestatic liver injury: impact on Nrf2\/NF-kappaB\/NLRP3\/Caspase-1\/IL-1beta\/GSDMD signalling","volume":"322","author":"Khayat","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.jbc.2026.113508_bib12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0003-9861(95)90023-3","article-title":"Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes","volume":"320","author":"Rifkind","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jbc.2026.113508_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.jbc.2026.113508_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.116294","article-title":"Lipid metabolism: a molecular switch to control inflammation","volume":"173","author":"Cheng","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jbc.2026.113508_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/eurheartj\/ehaf493","article-title":"Arachidonic acid fuels inflammation by unlocking macrophage protein phosphatase 5 after myocardial infarction","volume":"47","author":"Chen","year":"2026","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jbc.2026.113508_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.plefa.2018.03.004","article-title":"Omega-6 fatty acids and inflammation","volume":"132","author":"Innes","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.jbc.2026.113508_bib17","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3390\/cells10051107","article-title":"Fibrotic events in the progression of cholestatic liver disease","volume":"10","author":"Wu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2026.113508_bib18","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1007\/s11357-023-01059-y","article-title":"Mitochondrial complex I inhibition triggers NAD(+)-independent glucose oxidation via successive NADPH formation, \"futile\" fatty acid cycling, and FADH(2) oxidation","volume":"46","author":"Abrosimov","year":"2024","journal-title":"Geroscience"},{"key":"10.1016\/j.jbc.2026.113508_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2026.101731","article-title":"Dietary lauric acid suppresses inflammation, cholestasis, hepatocyte injury, and senescence in 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine-induced inflammatory cholangiopathy","volume":"20","author":"Ghosh","year":"2026","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jbc.2026.113508_bib20","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.3892\/mmr.2015.4159","article-title":"Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis","volume":"12","author":"Lian","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jbc.2026.113508_bib21","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jhep.2014.06.025","article-title":"Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease","volume":"61","author":"Pereira-Fantini","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jbc.2026.113508_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/srep39264","article-title":"Altered systemic bile acid homeostasis contributes to liver disease in pediatric patients with intestinal failure","volume":"6","author":"Xiao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.113508_bib23","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1172\/JCI19974","article-title":"Hepatoprotection via the IL-6\/Stat3 pathway","volume":"112","author":"Taub","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.113508_bib24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/JLB.3RU1018-378RR","article-title":"M2b macrophage polarization and its roles in diseases","volume":"106","author":"Wang","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jbc.2026.113508_bib25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/s41467-018-03764-1","article-title":"Macrophage-derived IL-1beta\/NF-kappaB signaling mediates parenteral nutrition-associated cholestasis","volume":"9","author":"El Kasmi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.113508_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MOG.0000000000000814","article-title":"Macrophages in cholangiopathies","volume":"38","author":"Bruneau","year":"2022","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.jbc.2026.113508_bib27","doi-asserted-by":"crossref","first-page":"7752","DOI":"10.1038\/s41598-023-33994-3","article-title":"Pharmacologic inhibition of HNF4alpha prevents parenteral nutrition associated cholestasis in mice","volume":"13","author":"Ghosh","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.113508_bib28","doi-asserted-by":"crossref","first-page":"206ra137","DOI":"10.1126\/scitranslmed.3006898","article-title":"Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease","volume":"5","author":"El Kasmi","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2026.113508_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1065790","article-title":"Stimulation of the farnesoid X receptor promotes M2 macrophage polarization","volume":"14","author":"Jaroonwitchawan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2026.113508_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.170428","article-title":"Farnesoid X receptor mediates macrophage-intrinsic responses to suppress colitis-induced colon cancer progression","volume":"9","author":"Dong","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jbc.2026.113508_bib31","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1292\/jvms.16-0347","article-title":"Discovery of anti-inflammatory role of prostaglandin D(2)","volume":"78","author":"Murata","year":"2016","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.jbc.2026.113508_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000802","article-title":"Arachidonic acid metabolism in metabolic dysfunction-associated steatotic liver disease and liver fibrosis","volume":"9","author":"Ma","year":"2025","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jbc.2026.113508_bib33","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3390\/metabo12121238","article-title":"Role of oxylipins in the inflammatory-related diseases NAFLD, obesity, and type 2 diabetes","volume":"12","author":"Misheva","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.jbc.2026.113508_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","article-title":"TGF-beta in progression of liver disease","volume":"347","author":"Dooley","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.jbc.2026.113508_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fphys.2012.00012","article-title":"Biological significance of local TGF-beta activation in liver diseases","volume":"3","author":"Hayashi","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jbc.2026.113508_bib36","article-title":"TGF-beta inhibitors: the future for prevention and treatment of liver fibrosis?","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2026.113508_bib37","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.cellsig.2012.04.015","article-title":"FXR ligands protect against hepatocellular inflammation via SOCS3 induction","volume":"24","author":"Xu","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jbc.2026.113508_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn4558","article-title":"FXR adapts hepatic mitochondrial function to increased substrate oxidation in patients with obesity","volume":"17","author":"Panzitt","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2026.113508_bib39","article-title":"Intestinal farnesoid X receptor signaling controls hepatic fatty acid oxidation","volume":"1867","author":"Lu","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jbc.2026.113508_bib40","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1126\/science.1164551","article-title":"Function of mitochondrial Stat3 in cellular respiration","volume":"323","author":"Wegrzyn","year":"2009","journal-title":"Science"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582602380X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582602380X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:42:42Z","timestamp":1793220162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582602380X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S002192582602380X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113508","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Farnesoid X receptor activates STAT3 to promote fatty acid oxidation and suppress inflammatory macrophage responses in cholestasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"113508"}}